Last updated: May 29, 2026

Application No. 17/614,563

ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF

Final Rejection

Filed

Nov 29, 2021

Priority

Jun 05, 2019 — nonprovisional of PCTIL2019050639

Examiner

IVICH, FERNANDO NMN

Art Unit

1678

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Yeda Research And Development Co. Ltd.

OA Round

2 (Final)

This examiner grants 43% of cases after interview

— +77.9% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 28 resolved cases, 2023–2026

Examiner Intelligence

IVICH, FERNANDO NMN View full profile →

Grants 43% of resolved cases

Career Allowance Rate

12 granted / 28 resolved

-17.1% vs TC avg

Strong +78% interview lift

Without

With

+77.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 11m

Avg Prosecution

28 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

6.8%

-33.2% vs TC avg

§103

50.9%

+10.9% vs TC avg

§102

6.8%

-33.2% vs TC avg

§112

9.8%

-30.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 28 resolved cases

Prosecution Timeline

Nov 29, 2021

Application Filed

May 06, 2025

Non-Final Rejection mailed

Aug 04, 2025

Response Filed

Sep 11, 2025

Final Rejection mailed

May 11, 2026

Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

17/729,494

Patent 12618835

MULTIPLEX MICROELECTRODE ARRAY FOR DETECTION OF PROTEASES AS BIOMARKERS

4y 0m to grant Granted May 05, 2026

17/437,118

Patent 12607626

A Method for Separating Biomolecules

4y 7m to grant Granted Apr 21, 2026

17/674,968

Patent 12571803

METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT'S RECOVERY FROM A BRAIN INJURY

4y 0m to grant Granted Mar 10, 2026

19/073,950

Patent 12540950

METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT’S RECOVERY FROM A BRAIN INJURY

11m to grant Granted Feb 03, 2026

17/995,261

Patent 12523662

ANTIBODIES THAT SPECIFICALLY BIND PEPTIDES ASSOCIATED WITH THE PRIMARY IMMUNODEFICIENCIES: WISKOTT-ALDRICH SYNDROME AND X-LINKED AGAMMAGLOBULINEMIA

3y 3m to grant Granted Jan 13, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

43%

Grant Probability

99%

With Interview (+77.9%)

3y 11m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 28 resolved cases by this examiner. Grant probability derived from career allowance rate.